Advertisement
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Business

Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion

March 31, 2026
The Wall Street Journal - Business
Scroll

The deal will expand Biogen’s portfolio in immunology and rare-disease medicines.

Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Read Full Article
The Wall Street Journal - Business
The Wall Street Journal - Business

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America
Bias: lean right
Advertisement
You might also like

Explore More